Cellular and Molecular Immunology - Table of Contents alert Volume 15 Issue 2

If you are unable to see the message below, click here to view.

Advertisement Nature Outlook: Cancer immunotherapy  Drugs that mobilize our immune systems against cancer are dramatically improving care for many people, and research is rapidly moving ahead in the lab and the clinic.  Access this Outlook free online for more Produced with support from  F. Hoffmann-La Roche Ltd  & Medimmune  Produced with support of a grant from Merck & Co., Inc.   TABLE OF CONTENTS Volume 15, Issue 2 (February 2018) In this issue Research Highlights Research Articles Letters to the Editor Also new AOP   Advertisement nature.com webcasts  Springer Nature presents a custom webcast on: Transforming Translational Research: CANscript™ - A Better Predictive Model For Oncology Date: Tuesday, February 20, 2018  Register for the webcast and live Q&A session  Sponsored by: Mitra Biotech  Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement nature.com webcasts Springer Nature presents a custom webcast on: Multiple Assays of the Anti-Apoptotic BCL-2 Family Date: Wednesday, February 28, 2018  Register for the webcast and live Q&A session  Sponsored by: Millipore Sigma  Research Highlights Top Dietary therapy may be sufficient for type 1 diabetes treatment Shuoyang Liu and Xin Chen Cell Mol Immunol 2018 15: 85-87; advance online publication, July 10, 2017; 10.1038/cmi.2017.56 Full Text Microbiota or short-chain fatty acids: which regulates diabetes? Chang H Kim Cell Mol Immunol 2018 15: 88-91; advance online publication, July 17, 2017; 10.1038/cmi.2017.57 Full Text Gut microbiota metabolites for sweetening type I diabetes Thamer Aljutaily, Marta Consuegra-Fernández, Fernando Aranda, Francisco Lozano and Eduardo Huarte Cell Mol Immunol 2018 15: 92-95; advance online publication, July 31, 2017; 10.1038/cmi.2017.65 Full Text Clonal expansion shapes the human Vδ1T cell receptor repertoire Serena Meraviglia and Francesco Dieli Cell Mol Immunol 2018 15: 96-98; advance online publication, July 24, 2017; 10.1038/cmi.2017.66 Full Text Research Articles Top MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production Xiang Liu, Xiaoping Su, Sheng Xu, Huamin Wang, Dan Han, Jiangxue Li, Mingyan Huang and Xuetao Cao Cell Mol Immunol 2018 15: 99-110; advance online publication, September 11, 2017; 10.1038/cmi.2017.82 Abstract | Full Text Poly-gamma-glutamic acid from Bacillus subtilis upregulates pro-inflammatory cytokines while inhibiting NLRP3, NLRC4 and AIM2 inflammasome activation Huijeong Ahn, Seung Goo Kang, Sung-il Yoon, Pyeung-Hyeun Kim, Doo Kim and Geun-Shik Lee Cell Mol Immunol 2018 15: 111-119; advance online publication, May 2, 2016; 10.1038/cmi.2016.13 Abstract | Full Text Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica Yuanyuan Xie, Huiqin Wen, Ke Yan, Shushu Wang, Xuesong Wang, Jian Chen, Yuanling Li, Yuanhong Xu, Zhengrong Zhong, Jilong Shen and Deyong Chu Cell Mol Immunol 2018 15: 120-134; advance online publication, May 9, 2016; 10.1038/cmi.2016.21 Abstract | Full Text HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer Shuxun Liu, Lin Yi, Ma Ling, Jinxia Jiang, Lijun Song, Juan Liu and Xuetao Cao Cell Mol Immunol 2018 15: 135-145; advance online publication, June 27, 2016; 10.1038/cmi.2016.33 Abstract | Full Text Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library Longlong Luo, Shi Wang, Xiaoling Lang, Tingting Zhou, Jing Geng, Xinying Li, Chunxia Qiao, Jiannan Feng, Beifen Shen, Ming Lv and Yan Li Cell Mol Immunol 2018 15: 146-157; advance online publication, August 8, 2016; 10.1038/cmi.2016.38 Abstract | Full Text CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes Soizic Garaud, Taher E Taher, Marjolaine Debant, Miguel Burgos, Sarra Melayah, Christian Berthou, Kaushal Parikh, Jacques-Olivier Pers, Damien Luque-Paz, Gilles Chiocchia, Maikel Peppelenbosch, David A Isenberg, Pierre Youinou, Olivier Mignen, Yves Renaudineau and Rizgar A Mageed Cell Mol Immunol 2018 15: 158-170; advance online publication, August 8, 2016; 10.1038/cmi.2016.42 Abstract | Full Text uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis Yan Liu, Yun Feng Pan, You-qiu Xue, Lin-kai Fang, Xing-hua Guo, Xin Guo, Meng Liu, Bi-yao Mo, Meng-ru Yang, Fang Liu, Yun-ting Wu, Nancy Olsen and Song Guo Zheng Cell Mol Immunol 2018 15: 171-181; advance online publication, January 16, 2017; 10.1038/cmi.2016.60 Abstract | Full Text Letters to the Editor Top Multi-epitope vaccines: a promising strategy against tumors and viral infections Lifang Zhang Cell Mol Immunol 2018 15: 182-184; advance online publication, September 11, 2017; 10.1038/cmi.2017.92 Full Text Non-coding RNA: a key regulator of the pathogenicity and immunity of Flaviviridae viruses infection Zhiyi Zhang, Lifang Jiang and Gucheng Zeng Cell Mol Immunol 2018 15: 185-186; advance online publication, October 9, 2017; 10.1038/cmi.2017.86 Full Text Revisiting GM-CSF as an adjuvant for therapeutic vaccines Weidong Zhao, Gan Zhao and Bin Wang Cell Mol Immunol 2018 15: 187-189; advance online publication, October 23, 2017; 10.1038/cmi.2017.105 Full Text Gut-homing α4β7 CD4+ T cells: potential key players in both acute HIV infection and HIV-associated cancers Yang Wang, Xiaofan Lu, Hao Wu and Wei Li Cell Mol Immunol 2018 15: 190-192; advance online publication, October 30, 2017; 10.1038/cmi.2017.104 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cellular & Molecular Immunology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.